verve therapeutics eli lilly - Search News

News

Eli Lilly Buys Verve Therapeutics

The Wall Street Journal on MSN · 19h

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio.Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Barron's on MSN · 22h

Eli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Pharmaceutical Technology · 2h

Eli Lilly lands “bargain” deal to acquire Verve Therapeutics for $1.3bn

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising to $1.3bn.

21hon MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Verve Therapeutics’ stock was rallying by a record 80% on Eli Lilly’s premium purchase price for the drug-development company ...

44m

Lock In The 81.5% Run: Initiating Verve With A Sell

Eli Lilly's $1.3B acquisition of Verve Therapeutics caused a sharp rally, but with shares above the buyout price, I recommend ...

Eli Lilly to expand cardiovascular disease pipeline with $1.3bn Verve acquisition

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results